The Union-Tribune reports that "Arena Pharmaceuticals failed to impress analysts and investors yesterday when it revealed the results of its first phase 3 clinical trial for the drug lorcaserin."

FTC Stops Spammers Selling Bogus Hoodia Weight-Loss Products and Human Growth Hormone Anti-Aging Products
Alleges Defendants Send Illegal E-mails via Web Form Hijacking and Make False and Unsubstantiated Product Claims